Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
All content for Lung Cancer Considered is the property of IASLC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
Lung Cancer Considered
45 minutes 40 seconds
2 months ago
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.
Guests:
Cheryl Ho, MD, FRCPC
Thoracic Oncologist, BC Cancer
Clinical Associate Professor and Fellowship Program Director
University of British Columbia
Maria Velez Velez, MD, MS
Clinical Instructor, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Lung Cancer Considered
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
